Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system

Laszlo Prokai, Alevtina D. Zharikova

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The centrally active thyrotropin-releasing hormone (TRH) analogue pGlu-Leu-Pro-NH2 ([Leu2]TRH) showed a significant increase in the extracellular acetylcholine concentration during its perfusion to the hippocampus in rats, and this effect was manifested upon the delivery of the analogue in much smaller quantities compared to TRH when measured by in vivo intracranial microdialysis. The neuropharmacodynamic efficacy of [Leu2]TRH upon intravenous administration was augmented by the use of a brain-targeting derivative in which the progenitor sequence of the mature peptide was embedded in a molecular architecture that promoted enhanced brain delivery, retention and in situ generation of the pharmacologically active molecule. Compared to the unmodified peptide, the targeting system significantly improved the cumulative effect of the treatment on extracellular acetylcholine levels in rats.

Original languageEnglish
Pages (from-to)268-274
Number of pages7
JournalBrain Research
Volume952
Issue number2
DOIs
StatePublished - 18 Oct 2002

Fingerprint

Thyrotropin-Releasing Hormone
Brain
Acetylcholine
Peptides
Microdialysis
Intravenous Administration
Hippocampus
Perfusion
Therapeutics

Keywords

  • Acetylcholine
  • Brain-delivery
  • In vivo microdialysis
  • TRH analogue

Cite this

@article{dc303e63ddce4602877495d5cb273b04,
title = "Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system",
abstract = "The centrally active thyrotropin-releasing hormone (TRH) analogue pGlu-Leu-Pro-NH2 ([Leu2]TRH) showed a significant increase in the extracellular acetylcholine concentration during its perfusion to the hippocampus in rats, and this effect was manifested upon the delivery of the analogue in much smaller quantities compared to TRH when measured by in vivo intracranial microdialysis. The neuropharmacodynamic efficacy of [Leu2]TRH upon intravenous administration was augmented by the use of a brain-targeting derivative in which the progenitor sequence of the mature peptide was embedded in a molecular architecture that promoted enhanced brain delivery, retention and in situ generation of the pharmacologically active molecule. Compared to the unmodified peptide, the targeting system significantly improved the cumulative effect of the treatment on extracellular acetylcholine levels in rats.",
keywords = "Acetylcholine, Brain-delivery, In vivo microdialysis, TRH analogue",
author = "Laszlo Prokai and Zharikova, {Alevtina D.}",
year = "2002",
month = "10",
day = "18",
doi = "10.1016/S0006-8993(02)03251-1",
language = "English",
volume = "952",
pages = "268--274",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system. / Prokai, Laszlo; Zharikova, Alevtina D.

In: Brain Research, Vol. 952, No. 2, 18.10.2002, p. 268-274.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system

AU - Prokai, Laszlo

AU - Zharikova, Alevtina D.

PY - 2002/10/18

Y1 - 2002/10/18

N2 - The centrally active thyrotropin-releasing hormone (TRH) analogue pGlu-Leu-Pro-NH2 ([Leu2]TRH) showed a significant increase in the extracellular acetylcholine concentration during its perfusion to the hippocampus in rats, and this effect was manifested upon the delivery of the analogue in much smaller quantities compared to TRH when measured by in vivo intracranial microdialysis. The neuropharmacodynamic efficacy of [Leu2]TRH upon intravenous administration was augmented by the use of a brain-targeting derivative in which the progenitor sequence of the mature peptide was embedded in a molecular architecture that promoted enhanced brain delivery, retention and in situ generation of the pharmacologically active molecule. Compared to the unmodified peptide, the targeting system significantly improved the cumulative effect of the treatment on extracellular acetylcholine levels in rats.

AB - The centrally active thyrotropin-releasing hormone (TRH) analogue pGlu-Leu-Pro-NH2 ([Leu2]TRH) showed a significant increase in the extracellular acetylcholine concentration during its perfusion to the hippocampus in rats, and this effect was manifested upon the delivery of the analogue in much smaller quantities compared to TRH when measured by in vivo intracranial microdialysis. The neuropharmacodynamic efficacy of [Leu2]TRH upon intravenous administration was augmented by the use of a brain-targeting derivative in which the progenitor sequence of the mature peptide was embedded in a molecular architecture that promoted enhanced brain delivery, retention and in situ generation of the pharmacologically active molecule. Compared to the unmodified peptide, the targeting system significantly improved the cumulative effect of the treatment on extracellular acetylcholine levels in rats.

KW - Acetylcholine

KW - Brain-delivery

KW - In vivo microdialysis

KW - TRH analogue

UR - http://www.scopus.com/inward/record.url?scp=0037131089&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(02)03251-1

DO - 10.1016/S0006-8993(02)03251-1

M3 - Article

C2 - 12376188

AN - SCOPUS:0037131089

VL - 952

SP - 268

EP - 274

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -